drugset / Trial / NCT03245437
Target Engagement and Response to Oxytocin
Phase 4
Completed
120 enrolled
University of California, Los Angeles
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will measure whether the engagement of intranasal oxytocin with a brain target is related to effects on learning during a social cognition training program.
Timeline
- Start
- 2018-01-04
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | — | Intranasal |